Literature DB >> 2305180

Evolution of antimicrobial susceptibility in isolates of the Bacteroides fragilis group in Spain.

J E García-Rodríguez1, J E García-Sánchez.   

Abstract

The species included in the Bacteroides fragilis group are the most frequent nontoxigenic anaerobic bacteria pathogenic to humans. The emergence and increase of resistance to antibiotics among this group make surveillance and state-of-the-art knowledge important. We studied the evolution of resistance to antibiotics in B. fragilis group organisms isolated at the University Clinical Hospital at Salamanca, Spain, from 1975 to 1987. No resistance to imipenem, chloramphenicol, or metronidazole was detected. The frequency of resistance to clindamycin was in the range of 6%-7%. Resistance to moxalactam, cefoxitin, mezlocillin, and piperacillin has increased steadily and is currently approximately 20%-25%.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2305180     DOI: 10.1093/clinids/12.supplement_2.s142

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  9 in total

1.  Trends in antimicrobial resistance among clinical isolates of the Bacteroides fragilis group from 1992 to 1997 in Montreal, Canada.

Authors:  A C Labbé; A M Bourgault; J Vincelette; P L Turgeon; F Lamothe
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

2.  Susceptibilities of members of the Bacteroides fragilis group to 11 antimicrobial agents.

Authors:  R Horn; J Lavallée; H G Robson
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

3.  Do antimicrobial susceptibility patterns of colonic isolates of Bacteroides species change after antibiotic prophylaxis with cefoxitine during elective abdominal surgery?

Authors:  Nurver Ulger Toprak; Bahadir M Güllüoğlu; Ozlem Cakici; M Levhi Akin; Pakize Demirkalem; Tuncay Celenk; Güner Söyletir
Journal:  World J Surg       Date:  2005-10       Impact factor: 3.352

4.  Survey of Bacteroides fragilis group susceptibility patterns in Canada.

Authors:  A M Bourgault; F Lamothe; D J Hoban; M T Dalton; P C Kibsey; G Harding; J A Smith; D E Low; H Gilbert
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

5.  Clinical significance of anaerobic bacteremias in a general hospital. A prospective study from 1988 to 1992.

Authors:  J Gómez; V Baños; J Ruiz; F Herrero; M Pérez; L Pretel; M Canteras; M Valdés
Journal:  Clin Investig       Date:  1993-08

6.  Comparative activities of eight quinolones against members of the Bacteroides fragilis group.

Authors:  M V Borobio; M Conejo; E Ramirez; A I Suarez; E J Perea
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

7.  Changes in the susceptibility of Bacteroides fragilis group organisms to various antimicrobial agents 1979-1989.

Authors:  C Betriu; C Cabronero; M Gomez; J J Picazo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-04       Impact factor: 3.267

Review 8.  Resistance of anaerobic bacteria to antimicrobial agents in Spain.

Authors:  F Baquero; M Reig
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-11       Impact factor: 3.267

9.  In vitro susceptibility of clinical isolates of Bacteroides fragilis and Bacteroides thetaiotaomicron in Japan.

Authors:  K Watanabe; K Ueno; N Kato; Y Muto; K Bandoh; Y Tanaka; R Jotwani; M Goto; K Shimada; K Shimizu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-11       Impact factor: 3.267

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.